Cameron Lacey

May 1, 2024 | bmjopen.bmj.com | Ben Beaglehole |Richard Porter |Katie M Douglas |Cameron Lacey

Introduction Major depressive disorder (MDD) is the most prevalent mental disorder in Aotearoa New Zealand (NZ).1 It is associated with a high burden of illness for individuals and families globally.2 MDD is also associated with high rates of physical comorbidity, substantial societal-level costs relating to reduced productivity and premature death by suicide.3 Established treatments for MDD are conventional antidepressant medications and psychotherapy.4 Each of these treatments and their...

Oct 27, 2023 | journals.sagepub.com | Jenni Manuel |Cameron Lacey |Suzanne Pitama |Ruth Cunningham

AbstractEating disorders are as common in Māori, the Indigenous people of Aotearoa-New Zealand, as they are in non-Māori; however, research has focused on the experiences of non-Māori. This paper will describe explanatory factors, treatment experiences and what helps with recovery for Māori. Kaupapa Māori research methodology informed the methods and analysis.

Aug 17, 2023 | onlinelibrary.wiley.com | Marie Crowe |Jenni Manuel |Dave Carlyle |Cameron Lacey

BACKGROUND There is rapidly emerging evidence of the efficacy of using psilocybin in the treatment of ‘treatment-resistant depression’ (TRD) (Romeo et al., 2020). Two studies (Carhart-Harris et al., 2016, 2021) demonstrated that psilocybin-assisted supportive therapy for TRD contributed to improvements in depressive symptoms.